Christopher Lo is an Associate at Enavate Sciences. Previously, he worked at Roivant to evaluate investments and develop novel medicines. Most recently, he was involved in clinical development of gene therapies for rare diseases at Aruvant Sciences. Mr. Lo graduated from the Jerome Fisher Program in Management & Technology, receiving a B.A.S. in Bioengineering from the University of Pennsylvania and a B.S. in Economics and Statistics from Wharton.